engaging with stakeholders to solve car-t supply chain and regulatory issues
Published 2 years ago • 85 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
4:12
car-t supply chains in europe
-
1:35
key mechanisms of resistance to car t-cell therapy
-
1:51
regulatory and commercialization challenges with car t-cell therapy
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
5:43
strategies to overcome the current obstacles in car-t manufacturing
-
1:18
working together - car t-cell logistics
-
3:59
strategies to improve car t-cell manufacturing
-
2:48
innovative new approaches required for the practical implementation of car t-cell therapy
-
3:38
mechanisms of resistance to car-t in all: t-cell fitness, antigen loss and immunological rejection
-
1:42
challenges associated with car-t cell production
-
2:47
current challenges with car t-cell therapy
-
19:39
t-cell engagers: targets, challenges and opportunity
-
1:19
challenges for access to car t-cell therapy
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
3:03
the impact of salvage and bridging therapy on car t-cell therapy outcomes in b-all: an itt analysis
-
1:13
challenges of dual-targeted car t-cell therapy